University of Oxford

University of Oxford  
Health - Dec 10
It is with great sadness that we learnt of the death of Sir David Weatherall this weekend. Sir David Weatherall, fondly called 'Prof' by those who knew him, was a general physician, a haematologist and clinician scientist whose research focused on the genetics of blood disorders affecting haemoglobin, such as thalassaemia and sickle cell disease.
Life Sciences - Dec 7

The University of Oxford today announces initial proposals for the location, character and provisional leadership of a new graduate college.

Astronomy - Dec 5

A new toy model proposes a way to unify dark energy and dark matter in our Universe. Normal matter is the basic building block of humans, plants, and the solar system, but yet only comprises 5% of all the matter in the Universe.

Life Sciences - Dec 4

Researchers at the University of Oxford receive national award for public engagement work about animal research.

Health - Dec 3

A study to be published in The Lancet Infectious Diseases on World AIDS Day shows the extraordinary global genetic diversity of HIV and highlights just how big the challenge is to develop a vaccine to combat the global spread of HIV.

Innovation - Dec 5

PalaeoPi, a spinout company from the University of Oxford, is driving down the costs of high-throughput, high-resolution, close-range photogrammetry through research and automation, bringing photo to 3D to all.

Environment - Dec 5

It's official, the humble gecko is the Maserati of reptiles.  Despite being just a few centimetres long, the gecko is known for its superior acrobatic skills and ability to power through the most challenging terrain, such as, climbing the tallest trees and running across cold, slippery ice.

Health - Dec 3

The UK's first dedicated Vaccines Manufacturing Innovation Centre (VMIC), annnounced by Business Secretary Greg Clark MP, represents a major commercial opportunity and also a new front line in the nation's defence against global pandemic threats.

Life Sciences - Nov 30

A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's.

website preview